Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced it has ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Management Comments Mergers and Acquisitions

Piper Jaffray Upgrades Meridian Biosciences (VIVO) to NeutralMay 1, 2019 2:36 AM Meridian Bioscience Announces Agreement to Acquire Business of GenePOC; Adds State-of-the-Art Molecular Diagnostics PlatformApril 30, 2019 9:40 AM